The best treatment is not a winner in the abstract. It is a route that can work here.

A useful formulation holds several layers at once: symptoms and time course; body, sleep and medical factors; learning, prediction and avoidance; trauma and attachment; substances and medication; relationships, money, work and housing; values, culture and the person’s own explanation. It stays provisional. New information is allowed to change the map.

Flow Hijacked adds a steering question: which transition is currently both high-value and reachable? Sometimes that is trauma processing. Sometimes it is sleep, withdrawal management, food, medication stabilization, transport, family safety or one appointment that actually happens. Choosing a smaller first move is not reducing the person; it is respecting the state from which action must begin.

CBT can work with interpretations and behaviour; behavioural activation with action before motivation; interpersonal therapy with grief and role transitions; exposure-based approaches with avoidance and new learning; psychodynamic therapy with recurring relational patterns; DBT with skills, crises and a life worth living; ACT with willingness and values; family-focused work with communication and relapse prevention. Integrative therapy can be coherent when the reasons for combining methods are explicit.

Common factors—trust, shared goals, a credible explanation and repair after misunderstanding—matter across therapies, but they do not make methods interchangeable. Fit includes the problem being treated, evidence, therapist competence, culture, pace, cost and whether the person can remain engaged. A warm treatment that does not address the maintaining process can stall; a technically correct treatment without safety or alliance can also fail.

Medication decisions depend on the condition, state and person. An antidepressant question in unipolar depression differs from one in bipolar depression; an antipsychotic used during acute mania may have a different long-term role; a sedating effect can be relief in one interval and disabling in another. Expected benefit, onset, side effects, interactions, monitoring, pregnancy considerations, substance use, prior response and discontinuation all belong in shared decision-making.

The brain adapts to many psychiatric medicines, so abrupt stopping can produce withdrawal, rebound or recurrence that may be mistaken for proof about the underlying illness. This does not mean a medication must continue forever. It means continuation, tapering and switching are clinical plans, not tests of willpower.

ECT is among the most effective acute treatments for selected severe depressive states and can be life-saving, while carrying anaesthetic and cognitive burdens that require consent and follow-up. rTMS and iTBS are non-invasive options for selected depression pathways. Ketamine or esketamine can act rapidly for some people but require screening, monitoring, transport, continuity and a plan beyond the acute response.

Psychedelic- or MDMA-assisted treatment remains a highly structured research and regulatory question, not a synonym for taking a substance in a therapeutic mood. Screening, therapist training, session length, preparation, integration, cardiovascular and psychiatric risk, blinding and abuse potential are part of the intervention. Experimental devices and biomarkers should be described as research platforms, not consumer promises.

Treatment fit is dynamic. A person may need stabilization before intensive processing, telehealth before travel becomes possible, medication before attention can hold therapy, or a relational repair before trust returns. Fit can also change after side effects, new risk, parenthood, work, housing loss or recovery from substance use. Reassessment is not failure; it is how care remains responsive.

A good plan names the next review and the handoff. Who notices deterioration? Who can be contacted? What counts as meaningful improvement? Which burden is unacceptable? What is the route back after a missed appointment, a lapse or a difficult week? These questions turn treatment from an isolated event into a recovery ecology.